Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Boehringer Ingelheim presents positive Dulcolax trial data

Boehringer Ingelheim presents positive Dulcolax trial data

10th May 2010

Boehringer Ingelheim has published new clinical data which supports the efficacy of its bestselling laxative treatment Dulcolax.

According to new information published during Digestive Disease Week 2010, the bisacodyl-based drug has been proven to deliver improvements on all measured symptoms of constipation in a placebo-controlled 268-patient study.

This trial also showed that use of the drug can help patients to experience an improved quality of life, while the safety profile of Dulcolax was also reinforced.

Gastroenterology expert Professor Stefan Muller-Lissner, of Park-Klinik Weissensee in Berlin, said: “Oral bisacodyl proved to be an effective, well-tolerated treatment for patients with constipation.”

According to Boehringer Ingelheim, Dulcolax is currently the best-selling laxative product in the world and has been met with a high level of satisfaction from patients using the treatment.

Earlier this month, the company announced that it will be working together with Micromet to develop a BiTE antibody-based treatment for multiple myeloma.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.